ED
CELG

Exane Derivatives’s Celgene Corp CELG Stock Holding History

Exane Derivatives’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,013
Closed -$101K – 716
2019
Q3 		$101K Hold
1,013
– – 0.02% 318
2019
Q2 		$93.6K Sell
1,013
-653
-39% -$62K 0.02% 338
2019
Q1 		$157K Sell
1,666
-988
-37% -$86.4K 0.03% 251
2018
Q4 		$170K Buy
2,654
+2,600
+4,815% +$192K 0.03% 266
2018
Q3 		$4.83K Sell
54
-752
-93% -$66.5K ﹤0.01% 465
2018
Q2 		$64.6K Sell
806
-3,624
-82% -$301K 0.01% 369
2018
Q1 		$390K Buy
4,430
+2,464
+125% +$237K 0.08% 174
2017
Q4 		$205K Buy
1,966
+1,247
+173% +$141K 0.04% 236
2017
Q3 		$105K Sell
719
-117
-14% -$15.9K 0.02% 252
2017
Q2 		$109K Sell
836
-127
-13% -$15.6K 0.02% 266
2017
Q1 		$120K Sell
963
-828
-46% -$99.1K 0.03% 217
2016
Q4 		$207K Sell
1,791
-207
-10% -$23.1K 0.04% 201
2016
Q3 		$209K Buy
+1,998
New +$216K 0.03% 204
2016
Q2 		– Sell
-2,633
Closed -$264K – 656
2016
Q1 		$264K Buy
2,633
+114
+5% +$11.7K 0.04% 178
2015
Q4 		$302K Buy
2,519
+502
+25% +$58.1K 0.04% 139
2015
Q3 		$218K Buy
2,017
+771
+62% +$95.7K 0.03% 182
2015
Q2 		$144K Buy
+1,246
New +$142K 0.02% 229
2015
Q1 		– Sell
-52
Closed -$5.82K – 582
2014
Q4 		$5.82K Buy
+52
New +$5.48K ﹤0.01% 427

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Exane Derivatives's CELG Position: Q4 2019 in Review

Exane Derivatives sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,013 shares — an estimated $101K sold.

Exane Derivatives first reported a position in CELG in Q4 2014 and held it in 18 quarters. The position peaked at $390K in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Exane Derivatives reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Exane Derivatives sold 1,013 Celgene Corp shares in Q4 2019, an estimated $101K.
  • Exane Derivatives first reported a position in Celgene Corp in Q4 2014 and held it in 18 quarters.
  • Exane Derivatives's Celgene Corp position peaked at $390K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.